Add BrightSurf on Google Email

The Lancet


Acinetobacter baumannii -- dangerously increasing its profile as a health-care-associated infection

The Lancet Infectious Diseases review highlights the growing concern of Acinetobacter baumannii infections, which can be caused by environmental exposure, skin colonization, or hospital-acquired conditions. Researchers emphasize the need for strict hygiene compliance and further research on antibiotic treatment options to prevent major...

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateNov 17, 2008

Obama and health: Change can happen

The Lancet Editorial suggests that President-elect Barack Obama's administration should prioritize health system strengthening to address the uninsured US residents. The plan includes payment choices, universal children's health insurance, and pre-existing condition coverage.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 13, 2008

WHO funding does not match global disease burdens

A study found that the World Health Organization's (WHO) budget allocations do not align with global disease burdens. The WHO allocated 87% of its budget to infectious diseases, while non-communicable diseases received only 12%. This disparity in funding is concerning, particularly for injuries and violence, which are largely underfunded.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 30, 2008

Much of malaria burden alleviated in the Gambia

Between 1999-2007, malaria incidence and mortality declined significantly in The Gambia thanks to increased funding and targeted interventions for pregnant women and young children. Proportions of malaria-positive slides decreased by up to 82% and deaths attributed to malaria fell by 100% in some hospitals.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 30, 2008

China faces daunting challeges to heatlh equity

China is facing significant challenges to health equity, with rural infant mortality rates nearly five times higher than in urban areas. The country has established health insurance schemes, but faces issues with market failures, inadequate government investment, and inequity in social determinants of health.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 19, 2008

China has improved maternal and newborn health but health affordability must be addressed in future

China has made significant strides in providing maternal and newborn health services, with coverage increasing from 20% in rural areas to 62% in 2003. However, the country still struggles with non-communicable diseases, smoking cessation, and affordability of healthcare, with 438 million people facing difficulties accessing care in 2003.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 19, 2008

The Lancet series on health system reform in China

The Lancet Series on Health System Reform in China brings together scientific evidence on China's major health challenges and its health strategies. The series aims to foster collaboration between China, the World Health Organization, and international partners to strengthen the Chinese people's healthcare.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 19, 2008

New drug class: Angina

A new drug class, ranolazine, has been approved for the treatment of chronic stable angina, providing a safe and effective alternative to existing treatments. Ranolazine has been shown to reduce anginal episodes by one attack per week and extend exercise time before an angina attack develops, with benefits seen in men more than women.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 9, 2008